DR. ANTONIOS O ALIPRANTIS, M.D.
Osteopathic Medicine at Boylston St, Boston, MA
License number
Massachusetts 217617
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
2
850 Boylston St STE 130, Boston, MA 02467
111 Cypress St, Brookline, MA 02445
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-9519
(617) 732-9577 (Fax)
(857) 307-0896
(617) 732-9577 (Fax)
(857) 307-0896
Professional information
Instructor At Brigham And Women's Hospital
Position:
Assistant Professor at Brigham and Women's Hospital
Location:
Greater Boston Area
Industry:
Medical Practice
Work:
Brigham and Women's Hospital
since Jul 2009
-
Assistant Professor
Education:
New York University 1989 - 1993
BA, Biochemistry
BA, Biochemistry
Dr. Antonios O Aliprantis, Chestnut Hill MA - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
850 Boylston St STE 130, Chestnut Hill 02467
(617) 732-9519 (Phone)
(617) 732-9519 (Phone)
Conditions:
Adhesive Capsulitis, Arthritis, Rheumatoid Arthritis
Certifications:
Internal Medicine, 2004, Rheumatology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
850 Boylston St STE 130, Chestnut Hill 02467
Brigham and Women's Hospital
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
New York University School Of Medicine
Graduated: 2001
New York University Med Center Tisch Hospital
Graduated: 2003
Brigham and Women's Hospital
Graduated: 2007
New York University School Of Medicine
Graduated: 2001
New York University Med Center Tisch Hospital
Graduated: 2003
Brigham and Women's Hospital
Graduated: 2007
Antonios Othon Aliprantis, Brookline MA
Specialties:
Rheumatologist
Address:
111 Cypress St, Brookline, MA 02445
850 Boylston St, Chestnut Hill, MA 02467
75 Francis St, Boston, MA 02115
850 Boylston St, Chestnut Hill, MA 02467
75 Francis St, Boston, MA 02115
Education:
Doctor of Medicine
Brigham & Women's Hospital - Fellowship - Rheumatology (Internal Medicine)
New York University Langone Medical Center - Internship - Internal Medicine
Brigham & Women's Hospital - Fellowship - Rheumatology (Internal Medicine)
New York University Langone Medical Center - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)
Antonios O Aliprantis, Boston MA
Specialties:
Internal Medicine, Rheumatology, Adult Medicine
Work:
Brigham and Women's Hospital
1 Jimmy Fund Way, Boston, MA 02115 Brigham and Women's Hospital
75 Francis St, Boston, MA 02115
1 Jimmy Fund Way, Boston, MA 02115 Brigham and Women's Hospital
75 Francis St, Boston, MA 02115
Education:
New York University (2001)
Molecules Involved In Regulation Of Osteoblast Activity And Osteoclast Activity, And Methods Of Use Thereof
US Patent:
2010018, Jul 22, 2010
Filed:
May 29, 2008
Appl. No.:
12/598495
Inventors:
Laurie H. Glimcher - West Newton MA, US
Dallas C. Jones - Brookline MA, US
Antonios O. Aliprantis - Allston MA, US
Dallas C. Jones - Brookline MA, US
Antonios O. Aliprantis - Allston MA, US
Assignee:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:
A61K 49/00, C40B 30/00, C40B 30/06
US Classification:
424 91, 506 7, 506 10
Abstract:
The present invention is based, at least in part, on the identification of molecules involved in the differentiation and/or activity of osteoblasts and osteoclasts. Accordingly, the present invention provides methods of identifying modulators of bone formation, mineralization, and/or osteoclastogenesis and methods for treating disorders that would benefit from modulation of bone formation, mineralization, and/or osteoclastogenesis using agents identified as described herein. The target biomolecules of these methods are, for example, the osteoblast regulators TA0K2 or DLG1 or P1N1 or LYK5 or M0BKL2C or MAP4K2 or PACSIN2 or DCAMKLI or D0CK4 or PARO1 or TA0K3 or TRPV6 or CLK1 or AAK1 or PRKCA or AKAP8 or DGKJ or SMARCB1 or CIB2 or STIK33 or STK 39 or NRGN or PIK3R1 or RASSF5 or FRAPI or STK3S or LATSI or LATS2 or STK38L or GEFT or TNNI3K or STK4 or RAF1 or ARFI or CI7orf1 or SMURF2. The assays may involve mesenchymal cells. Also screening assays using osteoclast regulators such as GCK or WASH or PPP2CB or PPP2R1A or CREBBP or CUL3 or FBXW1 or MELK or PLCLI or MAP3K3 or DLGH1 or NEK7 or JIRAK3 or RHOC or SLC4A2 or PLCB4 or B-RAF or BMPR2 or MAPK3 or NHEDC2 are proposed, e.g. using hemapoietic stem cell assays.
Molecules Involved In Regulation Of Osteoblast Activity And Osteoclast Activity, And Methods Of Use Thereof
US Patent:
2009005, Feb 26, 2009
Filed:
May 29, 2008
Appl. No.:
12/156008
Inventors:
Laurie H. Glimcher - West Newton MA, US
Dallas C. Jones - Brookline MA, US
Antonios O. Aliprantis - Allston MA, US
Dallas C. Jones - Brookline MA, US
Antonios O. Aliprantis - Allston MA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C40B 30/06, C40B 30/00, A61K 38/45, A61P 19/00
US Classification:
424 945, 506 7, 506 10
Abstract:
The present invention is based, at least in part, on the identification of molecules involved in the differentiation and/or activity of osteoblasts and osteoclasts. Accordingly, the present invention provides methods of identifying modulators of bone formation, mineralization, and/or osteoclastogenesis and methods for treating disorders that would benefit from modulation of bone formation, mineralization, and/or osteoclastogenesis using agents identified as described herein.